Skip to main content

Advertisement

SpringerLink
Log in

Systemic Taxotere Chemotherapy for Metastatic Tumor Pleurisy in Cats with Spontaneous Breast Cancer

  • Oncology
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Systemic and intrapleural chemotherapy for metastatic tumor pleurisy was carried out in cats with breast carcinoma. The animals (n=18) were divided into 2 groups. Cats of the systemic chemotherapy group received 3–6 courses of taxotere (30 mg/m2; n=7) or 3 courses of taxotere (20 mg/m2) in combination with doxorubicin (20 mg/m2 at 21-day intervals (n=5) during the adjuvant period of therapy for metastatic tumor pleurisy. Objective effect was attained in 10 (84.6%) cats: partial remission in 3 (25%) and complete remission in 7 (58.3%, p<0.05) cats. Metastatic pleurisy progressed in 2 (16.7%) cats. The median time to progression reached 1.79 months, median lifespan 2.8 months. The animals of intrapleural chemotherapy group (n=6) received 1–4 courses of cyclophosphamide (250 mg/m2) at 1-week interval during the adjuvant period without therapy for malignant pleurisy. Malignant pleurisy progressed in all cats. The median time to progression was equal to median lifespan (0.6 months). The therapy for malignant pleurisy in cats with breast cancer is regarded as the second-line chemotherapy with taxotere preferable as a monotherapy or in combination with doxorubicin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. M. B. Bychkov and E. M. Treshalina, Ros. Bioter. Zh., No. 2, 58 (2009).

  2. E. K. Voznyi and S. S. Buyanov, Mammologiya, No. 2, 44–49 (1993).

  3. N. I. Perevodchikova, Sovrem. Onkol., 3, No. 2, 66–69 (2001).

    Google Scholar 

  4. S. A. Tyulyandin, Prakt. Onkol., No. 2, 3–11 (2000).

  5. A. Hayes and S. Mooney, Vet. Clin. North Am. Small Animal Pract., 15, No. 3, 513–520 (1985).

    CAS  Google Scholar 

  6. K. Malinvszky, S. Johnston, P. Barrett-Lee, et al., Cancer Chemother. Pharmacol., 59, No. 3, 413–418 (2007).

    Article  Google Scholar 

  7. J. M. Nabholtz, C. Falkson, D. Campos, et al., J. Clin. Oncol., 21, No. 6, 968–975 (2003).

    Article  PubMed  CAS  Google Scholar 

  8. L. Palmeri, M. Vaglica, and S. Palmeri, Ther. Clin. Risk Manag., 4, No. 5, 1047–1059 (2008).

    PubMed  CAS  Google Scholar 

  9. V. J. Poirier, A. E. Hershey, K. E. Burgess, et al., J. Vet. Int. Med., 18, No. 2, 219–222 (2004).

    Article  CAS  Google Scholar 

  10. J. Viste, S. Myers, B. Singh, and E. Simko, Can. Vet. J., 43, No. 1, 33–37 (2002).

    PubMed  Google Scholar 

  11. K. Weijer and A. A. Hart, J. Natl. Cancer Inst., 70, No. 4, 709–716 (1983).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. N. N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow, Russia

    M. N. Yakunina & E. M. Treshalina

Authors
  1. M. N. Yakunina
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. M. Treshalina
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. N. Yakunina.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 150, No. 11, pp. 574–576, November, 2010

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yakunina, M.N., Treshalina, E.M. Systemic Taxotere Chemotherapy for Metastatic Tumor Pleurisy in Cats with Spontaneous Breast Cancer. Bull Exp Biol Med 150, 642–644 (2011). https://doi.org/10.1007/s10517-011-1211-5

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-011-1211-5

Key Words

Search

Navigation